share_log

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham重申買入Avadel Pharmicals,維持22美元的目標股價
Benzinga ·  05/08 09:16

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $22 price target.

尼德姆分析師阿米·法迪亞重申阿瓦德爾製藥公司(納斯達克股票代碼:AVDL)的買入並維持22美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論